Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MORCHER is a private German ophthalmic medical device company focused on products for eye surgery, particularly eye implants. The company develops, manufactures, and distributes intraocular lenses for cataract surgery as well as capsular tension rings, aniridia implants, and other specialty ocular implants. Founded by Kurt A. Morcher and rooted in a long history of ophthalmic innovation, the company emphasizes implant design and manufacturing for challenging anterior segment indications. MORCHER appears to operate primarily as a commercial-stage device manufacturer rather than a drug-development biotech, serving ophthalmic surgeons through its own channels and distributor networks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MORCHER.